|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schiffer CA: BCR-ABL tyrosine kinase
inhibitors for chronic myelogenous leukemia. N Engl J Med.
357:258–265. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El Jurdi N, Bankoff M, Klein A and Saif
MW: Perforation of the Colon during imatinib mesylate (Gleevec)
treatment in a patient with chronic myeloid leukemia (CML). Cureus.
8:e6602016.PubMed/NCBI
|
|
4
|
Kantarjian H, O'Brien S, Cortes J, Wierda
W, Faderl S, Garcia-Manero G, Issa JP, Estey E, Keating M and
Freireich EJ: Therapeutic advances in leukemia and myelodysplastic
syndrome over the past 40 years. Cancer. 113:1933–1952. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen R, Zhang J, Hu Y, Wang S, Chen M and
Wang Y: Potential antineoplastic effects of aloe-emodin: A
comprehensive review. Am J Chin Med. 42:275–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ismail S, Haris K, Abdul Ghani AR,
Abdullah JM, Johan MF and Mohamed Yusoff AA: Enhanced induction of
cell cycle arrest and apoptosis via the mitochondrial membrane
potential disruption in human U87 malignant glioma cells by aloe
emodin. J Asian Nat Prod Res. 15:1003–1012. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chun-Guang W, Jun-Qing Y, Bei-Zhong L,
Dan-Ting J, Chong W, Liang Z, Dan Z and Yan W: Anti-tumor activity
of emodin against human chronic myelocytic leukemia K562 cell lines
in vitro and in vivo. Eur J Pharmacol. 627:33–41. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin CH, Lin YM, Lai YL and Lee SY:
Mechanical properties, accuracy, and cytotoxicity of UV-polymerized
3D printing resins composed of BisEMA, UDMA, and TEGDMA. J Prosthet
Dent. 2019.(Epub ahead of print). View Article : Google Scholar
|
|
9
|
Jin RR, Chao R, Xi YM, Chen C, Chu HY, Li
M and Zhang H: Effects of AZT on leukemia cell line KG-1a
proliferation and telomerase activity. Zhongguo Shi Yan Xue Ye Xue
Za Zhi. 20:277–281. 2012.(In Chinese). PubMed/NCBI
|
|
10
|
Gu S, Chen C, Jiang X and Zhang Z:
Resveratrol synergistically triggers apoptotic cell death with
arsenic trioxide via oxidative stress in human lung adenocarcinoma
A549 cells. Biol Trace Elem Res. 163:112–123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang H, Gao P and Zheng J: Arsenic
trioxide inhibits cell proliferation and human papillomavirus
oncogene expression in cervical cancer cells. Biochem Biophy Res
Commun. 451:556–561. 2014. View Article : Google Scholar
|
|
12
|
Sun R, Eriksson S and Wang L:
Identification and characterization of mitochondrial factors
modulating thymidine kinase 2 activity. Nucleosides Nucleotides
Nucleic Acids. 29:382–385. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mattson DM, Ahmad IM, Dayal D, Parsons AD,
Aykin-Burns N, Li L, Orcutt KP, Spitz DR, Dornfeld KJ and Simons
AL: Cisplatin combined with zidovudine enhances cytotoxicity and
oxidative stress in human head and neck cancer cells via a
thiol-dependent mechanism. Free Radic Biol Med. 46:232–237. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chau D, Ng K, Chan TS, Cheng YY, Fong B,
Tam S, Kwong YL and Tse E: Azacytidine sensitizes acute myeloid
leukemia cells to arsenic trioxide by up-regulating the arsenic
transporter aquaglyceroporin 9. J Hematol Oncol. 8:462015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bar-Shavit R, Turm H, Salah Z, Maoz M,
Cohen I, Weiss E, Uziely B and Grisaru-Granovsky S: PAR1 plays a
role in epithelial malignancies: Transcriptional regulation and
novel signaling pathway. IUBMB Life. 63:397–402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim JH, Liu X, Wang J, Chen X, Zhang H,
Kim SH, Cui J, Li R, Zhang W, Kong Y, et al: Wnt signaling in bone
formation and its therapeutic potential for bone diseases. Ther Adv
Musculoskelet Dis. 5:13–31. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wagner ER, Zhu G, Zhang BQ, Luo Q, Shi Q,
Huang E, Gao Y, Gao JL, Kim SH, Rastegar F, et al: The therapeutic
potential of the wnt signaling pathway in bone disorders. Curr Mol
Pharmacol. 4:14–25. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Clevers H, Loh KM and Nusse R: Stem cell
signaling. An integral program for tissue renewal and regeneration:
Wnt signaling and stem cell control. Science. 346:12480122014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Holland JD, Klaus A, Garratt AN and
Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr
Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Undi RB, Gutti U, Sahu I, Sarvothaman S,
Pasupuleti SR, Kandi R and Gutti RK: Wnt signaling: Role in
regulation of haematopoiesis. Indian J Hematol Blood Transfus.
32:123–134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu S, Li F, Xing S, Zhao T, Peng W and Xue
HH: Hematopoietic and leukemic stem cells have distinct dependence
on tcf1 and lef1 transcription factors. J Biol Chem.
291:11148–11160. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jamieson CH, Ailles LE, Dylla SJ,
Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating
A, et al: Granulocyte-macrophage progenitors as candidate leukemic
stem cells in blast-crisis CML. New Engl J Med. 351:657–667. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fu J, Si L, Zhuang Y, Zhang A, Sun N, Li
D, Hao B and Ju X: Wnt/betacatenin inhibition reverses multidrug
resistance in pediatric acute lymphoblastic leukemia. Oncol Rep.
41:1387–1394. 2019.PubMed/NCBI
|
|
27
|
Yang W, Nam K, Ju JH, Lee KM, Oh S and
Shin I: S100A4 negatively regulates β-catenin by inducing the
Egr-1-PTEN-Akt-GSK3β degradation pathway. Cell Signal.
26:2096–2106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang PH, Huang CY, Chen MC, Lee YT, Yue
CH, Wang HY and Lin H: Emodin and aloe-emodin suppress breast
cancer cell proliferation through ER α inhibition. Evid Based
Complement Alternat Med. 2013:3761232013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han H, Li J, Feng X, Zhou H, Guo S and
Zhou W: Autophagy-related genes are induced by histone deacetylase
inhibitor suberoylanilide hydroxamic acid via the activation of
cathepsin B in human breast cancer cells. Oncotarget.
8:53352–53365. 2017.PubMed/NCBI
|
|
30
|
Liu H, Gu LB, Tu Y, Hu H, Huang YR and Sun
W: Emodin ameliorates cisplatin-induced apoptosis of rat renal
tubular cells in vitro by activating autophagy. Acta Pharmacol Sin.
37:235–245. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song P, Ye L, Fan J, Li Y, Zeng X, Wang Z,
Wang S, Zhang G, Yang P, Cao Z and Ju D: Asparaginase induces
apoptosis and cytoprotective autophagy in chronic myeloid leukemia
cells. Oncotarget. 6:3861–3873. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen Y and Zhang Y: Functional and
mechanistic analysis of telomerase: An antitumor drug target.
Pharmacol Ther. 163:24–47. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu A, Sha L, Shen Y, Huang L, Tang X and
Lin S: Experimental study on anti-metastasis effect of emodin on
human pancreatic cancer. Zhongguo Zhong Yao Za Zhi. 36:3167–3171.
2011.(In Chinese). PubMed/NCBI
|
|
34
|
Wei TN, Hu JD, Chen YY, Chen XJ, Liu TB
and Lu LH: Effect of emodin on induction of apoptosis in jurkat
cells and its possible mechanisms. Zhongguo Shi Yan Xue Ye Xue Za
Zhi. 17:1203–1206. 2009.(In Chinese). PubMed/NCBI
|
|
35
|
Tazzari PL, Cappellini A, Ricci F,
Evangelisti C, Papa V, Grafone T, Martinelli G, Conte R, Cocco L,
McCubrey JA and Martelli AM: Multidrug resistance-associated
protein 1 expression is under the control of the phosphoinositide 3
kinase/Akt signal transduction network in human acute myelogenous
leukemia blasts. Leukemia. 21:427–438. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Min H, Niu M, Zhang W, Yan J, Li J, Tan X,
Li B, Su M, Di B and Yan F: Emodin reverses leukemia multidrug
resistance by competitive inhibition and downregulation of
P-glycoprotein. PLoS One. 12:e01879712017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang J, Tang XM, Li H, Shi GY, Zhu P, Jin
HF and Yi J: Emodin sensitizes HeLa cell to arsenic trioxide
induced apoptosis via the reactive oxygen species-mediated
signaling pathways. Shi Yan Sheng Wu Xue Bao. 36:465–475. 2003.(In
Chinese). PubMed/NCBI
|
|
38
|
Zhao LM, Zhang LM, Liu JJ, Wan LJ, Chen
YQ, Zhang SQ, Yan ZW and Jiang JH: Synthesis and antitumor activity
of conjugates of 5-fluorouracil and emodin. Eur J Med Chem.
47:255–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang W, Sun YP, Huang XZ, He M, Chen YY,
Shi GY, Li H, Yi J and Wang J: Emodin enhances sensitivity of
gallbladder cancer cells to platinum drugs via glutathion depletion
and MRP1 downregulation. Biochem Pharmacol. 79:1134–1140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li J, Liu P, Mao H, Wanga A and Zhang X:
Emodin sensitizes paclitaxel-resistant human ovarian cancer cells
to paclitaxel-induced apoptosis in vitro. Oncol Rep.
21:1605–1610. 2009.PubMed/NCBI
|
|
41
|
Zeng Y, Liu A and Tong HF: Effect of
emodin combined gemcitabine on the growth and apoptosis of
pancreatic cancer cell line BxPC-3 in vitro. Zhongguo Zhong Xi Yi
Jie He Za Zhi. 31:552–554. 2011.(In Chinese). PubMed/NCBI
|
|
42
|
Sun Y, Wang X, Zhou Q, Lu Y, Zhang H, Chen
Q, Zhao M and Su S: Inhibitory effect of emodin on migration,
invasion and metastasis of human breast cancer MDA-MB-231 cells
in vitro and in vivo. Oncol Rep. 33:338–346. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Calogero A, Porcellini A, Lombari V,
Fabbiano C, Arcella A, Miscusi M, Ponti D and Ragona G: Sensitivity
to cisplatin in primary cell lines derived from human glioma
correlates with levels of EGR-1 expression. Cancer Cell Int.
11:52011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ferraro B, Bepler G, Sharma S, Cantor A
and Haura EB: EGR1 predicts PTEN and survival in patients with
non-small-cell lung cancer. J Clin Oncol. 23:1921–1926. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ragione FD, Cucciolla V, Criniti V, Indaco
S, Borriello A and Zappia V: P21Cip1 gene expression is modulated
by Egr1: A novel regulatory mechanism involved in the resveratrol
antiproliferative effect. J Biol Chem. 278:23360–23368. 2003.
View Article : Google Scholar : PubMed/NCBI
|
